Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Upgraded at Raymond James Financial

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) was upgraded by stock analysts at Raymond James Financial from an “underperform” rating to a “market perform” rating in a report issued on Tuesday, FinViz reports.

A number of other research firms have also commented on SENS. Weiss Ratings upgraded Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, November 4th. TD Cowen reiterated a “buy” rating and set a $15.00 target price on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, October 27th. Mizuho reduced their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Barclays started coverage on Senseonics Holdings, Inc. Common Stock in a report on Wednesday, October 7th. They set an “equal weight” rating and a $10.00 target price on the stock. Finally, Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

Shares of NASDAQ:SENS opened at $9.80 on Tuesday. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $10.64. The company’s 50 day moving average price is $9.12 and its two-hundred day moving average price is $7.26. The firm has a market cap of $409.64 million, a PE ratio of -4.39 and a beta of 1.04. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last released its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). The business had revenue of $19.56 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. Equities research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder acquired 13,953 shares of the stock in a transaction on Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the transaction, the director directly owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 4.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

Large investors have recently modified their holdings of the business. Integrated Wealth Concepts LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at $36,000. The Manufacturers Life Insurance Company bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth $65,000. State of Wyoming acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $67,000. Kestra Advisory Services LLC acquired a new stake in Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $68,000. Finally, Cetera Investment Advisers bought a new position in Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $85,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.